2 February 09:00 - 2 February 10:00
How has the pandemic affected the growth potential and what are the future prospects of the life science industry? Learn more about the view of life science professionals and investors. Will we experience a post-pandemic shift of focus for public innovation funding?
Speakers and panelists:
- Martina Banyay, co-founder and partner, One in 200
- Åsa Angel Voss, co-founder and partner, One in 200
- Lars Hammarström, Director and Head of Division Health, Vinnova
- Johan Christenson, partner, Healthcap
- Jonas Söderström, CEO, Biostock
The panel discussion will be moderated by Andreas Namslauer, Stockholm Science City.
When: February 2 at 9:00-10:00 amWhere: via link that you will recieve through email prior to the webinar
The registration is now closed, please contact anna.frejd@ssci.se if you would like to participate!
Registrering